Recombinant Mouse Prostaglandin E synthase (Ptges)

What is the functional role of Ptges in mouse models?

Ptges functions as a glutathione-dependent prostaglandin E synthase that catalyzes the conversion of prostaglandin H2 (PGH2) to prostaglandin E2 (PGE2) in the prostaglandin biosynthetic pathway . This terminal enzyme in the cyclooxygenase (COX)-2-mediated PGE2 biosynthesis is critical for inflammatory responses, as it is induced by proinflammatory cytokines such as interleukin-1β (IL-1β) . In mouse models, Ptges plays key roles in:

• Mediating acute pain during inflammatory responses

• Contributing to the pathogenesis of collagen-induced arthritis

• Regulating inflammatory responses in various tissues

• Participating in tumor progression mechanisms, particularly in immunosuppression

Knockout studies in mice have provided substantial evidence that Ptges contributes significantly to inflammatory disease pathogenesis and pain signaling pathways . Beyond its primary enzymatic function, Ptges also displays glutathione transferase and glutathione-dependent peroxidase activities, though at relatively lower levels compared to its prostaglandin synthase activity .

How does mouse Ptges expression change during inflammatory conditions?

Mouse Ptges expression is dynamically regulated during inflammatory conditions. The gene is robustly induced by proinflammatory stimuli, particularly by the cytokine interleukin-1β (IL-1β) . Additionally, the tumor suppressor protein p53 (TP53) can induce Ptges expression, suggesting a potential role in stress responses and apoptotic pathways .

In inflammatory microenvironments:

• Basal expression is typically low in most tissues under normal physiological conditions

• Rapid upregulation occurs following exposure to inflammatory stimuli

• Expression patterns vary across different tissue types, with particularly notable expression in immune cells, lung tissue, and gastrointestinal tissues

• The kinetics of expression typically correlate with the inflammatory response timeline

During cell death processes (including necrosis, pyroptosis, and apoptosis), Ptges-derived PGE2 is released and functions as a damage-associated molecular pattern (DAMP) that helps regulate inflammatory responses . This represents a significant negative feedback mechanism that prevents excessive inflammation following tissue damage.

What detection methods are most reliable for measuring mouse Ptges protein and activity?

For accurate detection and quantification of mouse Ptges protein and enzymatic activity, researchers should consider these validated methodologies:

For most reliable results, activity assays should measure the conversion of PGH2 to PGE2 using purified recombinant enzyme or tissue lysates under controlled conditions . The addition of glutathione as a cofactor is essential for optimal enzymatic activity assessment. PGE2 production can be quantified using enzyme immunoassay (EIA) or liquid chromatography-mass spectrometry (LC-MS) methods.

What are the optimal conditions for expressing and purifying recombinant mouse Ptges?

Successful expression and purification of functional recombinant mouse Ptges requires careful optimization of several parameters:

Expression Systems:

• Bacterial systems (E. coli): While cost-effective, may yield lower activity due to lack of post-translational modifications

• Mammalian cells (HEK293, CHO): Provide proper folding and modifications but at higher cost

• Insect cell systems (Sf9, High Five): Often the preferred compromise between yield and functionality

Expression Conditions:

• Temperature: Lower temperatures (16-25°C) often improve proper folding

• Induction timing: Induce at mid-log phase (OD600 ~0.6-0.8) for bacterial systems

• Expression duration: 16-24 hours typically yields optimal balance between quantity and quality

Purification Strategy:

• Initial capture: Immobilized metal affinity chromatography (IMAC) for His-tagged constructs

• Intermediate purification: Ion exchange chromatography to remove contaminants

• Polishing: Size exclusion chromatography for highest purity

Critical Factors for Maintaining Activity:

• Include glutathione in all buffers during purification (1-5 mM)

• Avoid freeze-thaw cycles; store purified protein with 10-20% glycerol

• Use mild detergents (0.05-0.1% Triton X-100) to maintain protein solubility as Ptges is a membrane-associated protein

• Maintain pH between 7.2-8.0 throughout the purification process

Post-purification validation should include SDS-PAGE, Western blotting, and enzyme activity assays to confirm both purity and functionality of the recombinant protein .

How can I design effective Ptges knockout and knockdown studies in mouse models?

Designing effective Ptges knockout and knockdown studies requires consideration of several key factors to ensure meaningful results:

Knockout Strategies:

• Global knockout approach:

  • Targeted deletion of Ptges exons (typically exons containing catalytic domains)

  • Phenotype assessment across multiple systems (inflammatory, cardiovascular, renal)

  • Consider embryonic lethality issues that may necessitate conditional approaches

• Conditional knockout design:

  • Use Cre-loxP system for tissue-specific or inducible deletion

  • Target tissues with high Ptges expression (macrophages, lung, kidney)

  • Implement tamoxifen-inducible systems for temporal control

• Knockdown approaches:

  • siRNA delivery via various carriers (lipid nanoparticles, viral vectors)

  • shRNA expression for longer-term suppression

  • Consider tissue-specific promoters for targeted expression

Critical Controls:

• Include littermate controls from heterozygous breeding

• Validate knockout efficiency at both mRNA and protein levels

• Assess potential compensatory upregulation of related enzymes (mPGES-2, cPGES)

• Measure PGE2 levels to confirm functional impact of knockout

Phenotyping Parameters:

When designing knockout studies, researchers should be aware that Ptges knockout in cancer models may still permit tumor formation in immunodeficient mice while preventing it in immunocompetent animals, highlighting the importance of immune system consideration in experimental design .

What are the validated methods for measuring PGE2 production in Ptges experimental systems?

Accurate measurement of PGE2 production is critical for evaluating Ptges function in experimental systems. The following validated methods can be employed:

Enzyme Immunoassay (EIA)/ELISA:

• Most commonly used method for routine PGE2 quantification

• Commercially available kits offer convenience and standardization

• Sensitivity typically in the pg/ml range

• Requires careful sample collection with COX inhibitors to prevent ex vivo synthesis

Liquid Chromatography-Mass Spectrometry (LC-MS/MS):

• Gold standard for absolute quantification and specificity

• Can simultaneously measure multiple prostanoids

• Allows distinction between closely related prostaglandin species

• Requires specialized equipment and expertise

Radioimmunoassay (RIA):

• Historically used but largely replaced by EIA/ELISA

• Still useful for certain applications requiring highest sensitivity

Sample Collection Considerations:

• Collect samples in the presence of COX inhibitors (indomethacin) to prevent artifactual production

• Process samples rapidly and maintain cold chain

• Use appropriate anticoagulants for blood samples (EDTA preferred)

• Consider the half-life of PGE2 (minutes) when designing collection protocols

Experimental Design Factors:

• Include both baseline and stimulated conditions (LPS, IL-1β) to assess dynamic range

• Compare PGE2 production in wildtype versus Ptges knockout/knockdown systems

• Correlate PGE2 levels with biological outcomes (inflammation markers, phenotypic changes)

• Consider the influence of culture conditions on PGE2 stability

When analyzing PGE2 production in cell death contexts, it's important to note that PGE2 is released during various forms of cell death, including necrosis, pyroptosis (ATP/LPS-induced), and apoptosis (cisplatin/etoposide-induced) .

How does Ptges contribute to immunosuppression mechanisms in cancer models?

Ptges plays a critical role in tumor-associated immunosuppression, particularly through its production of PGE2. Recent research has revealed several key mechanisms:

Direct Effects on Immune Cell Function:

• PGE2 derived from Ptges activity directly inhibits T cell proliferation and cytotoxicity

• Promotes T regulatory cell differentiation and function

• Suppresses NK cell activities and cytokine production

• Alters dendritic cell maturation and antigen presentation

Myeloid-Derived Suppressor Cell (MDSC) Recruitment:
Critical research in Gprc5a-knockout mouse models has demonstrated that Ptges/PGE2 signaling induces cytokines that recruit MDSCs to the tumor microenvironment . These MDSCs are crucial mediators of immunosuppression that:

• Directly inhibit T-cell functions

• Produce immunosuppressive cytokines

• Deplete essential amino acids from the tumor microenvironment

• Create oxidative stress that impairs immune effector cells

Tumor Cell Intrinsic Resistance:
Ptges/PGE2 signaling intrinsically endows tumor cells with resistance to T-cell cytotoxicity . This protective effect involves:

• Upregulation of anti-apoptotic proteins

• Modulation of checkpoint molecule expression

• Alteration of tumor cell metabolism

Therapeutic Implications:
Targeting Ptges in mouse tumor models shows significant promise, as PTGES inhibitors have been shown to:

• Suppress MDSC recruitment

• Restore T cell functions

• Significantly repress lung metastasis in Gprc5a-knockout mice

This research indicates that Ptges represents a critical link between inflammation, immunosuppression, and metastasis in the tumor microenvironment. Notably, Ptges-knockout tumor cells still form tumors in immunodeficient mice but fail to do so in immunocompetent animals, confirming that the primary role of Ptges in tumorigenicity operates through immune evasion mechanisms .

What is the relationship between Ptges and cellular stress responses?

Ptges functions at the intersection of cellular stress responses and inflammatory signaling, with several important relationships emerging from recent research:

p53-Mediated Regulation:

• The tumor suppressor p53 (TP53) can induce Ptges expression

• This suggests Ptges may participate in cellular responses to genotoxic stress

• Ptges induction may contribute to p53-mediated apoptosis through PGE2 production

Role in Cell Death-Associated Inflammation:
PGE2 produced by Ptges serves as a damage-associated molecular pattern (DAMP) released by dying cells . This PGE2 release:

• Occurs during multiple forms of cell death (necrosis, pyroptosis, apoptosis)

• Negatively regulates cell death-induced inflammatory responses

• Helps prevent excessive inflammation following tissue damage

• Creates a feedback loop that modulates immune responses to dying cells

Oxidative Stress Interactions:

• Ptges possesses glutathione-dependent peroxidase activity toward certain substrates like 5-hydroperoxyicosatetraenoic acid (5-HPETE)

• This suggests a potential role in managing oxidative stress products

• The glutathione requirement for Ptges activity creates a link to cellular redox status

ER Stress Connection:

• Emerging evidence suggests connections between ER stress pathways and Ptges regulation

• The unfolded protein response (UPR) may influence Ptges expression

• This relationship may be particularly relevant in diseases with prominent ER stress components

Understanding these relationships is crucial for researchers investigating Ptges in the context of cancer, inflammatory diseases, and cellular adaptation to stress. The multifaceted role of Ptges in stress responses highlights its potential as a therapeutic target in conditions characterized by dysregulated stress response pathways.

How do Ptges inhibitors affect different inflammatory disease models?

Ptges inhibitors demonstrate variable efficacy across different inflammatory disease models, reflecting the context-dependent roles of this enzyme. Here's a comparative analysis of effects in major disease models:

Key mechanistic differences to consider:

• Timing-dependent effects: Early inhibition often shows greater benefit than delayed intervention

• Cell-type specific responses: Effects vary based on which cells predominantly express Ptges in each model

• Compensatory mechanisms: Alternative prostaglandin production pathways may become activated

• Disease stage influence: Acute versus chronic inflammation models show different responses

In cancer models specifically, Ptges inhibitors show remarkable efficacy in suppressing MDSC recruitment, restoring T cell function, and significantly repressing metastasis . This indicates that targeting the Ptges/PGE2 axis is particularly valuable in conditions where immunosuppression plays a central role in disease pathogenesis.

Researchers should carefully consider these model-specific responses when designing studies with Ptges inhibitors and interpret findings in the context of the particular inflammatory mechanism being investigated.

How should researchers interpret conflicting data regarding Ptges function across different experimental systems?

When faced with conflicting data about Ptges function, researchers should implement a systematic approach to analysis and interpretation:

Source of Variability Assessment:

• Species differences:

  • Mouse Ptges may have subtle functional differences from human PTGES

  • Evolutionary conservation analysis should precede cross-species comparisons

  • Consider using humanized mouse models for translational studies

• Genetic background effects:

  • Different mouse strains show variable inflammatory responses

  • Document complete genetic background information in all studies

  • Use littermate controls and backcrossing to minimize background effects

• Methodological considerations:

  • Expression systems impact protein folding and post-translational modifications

  • Assay sensitivity and specificity vary considerably between laboratories

  • Standardize methodologies when comparing across studies

Resolution Framework for Conflicting Data:

• Contextual analysis:

  • Evaluate whether differences reflect context-dependent roles rather than contradictions

  • Consider tissue-specific effects and microenvironmental factors

  • Assess the impact of disease stage on observed phenotypes

• Dose-response relationships:

  • Biphasic effects may explain apparent contradictions

  • Determine whether threshold effects exist for Ptges activity

  • Quantify enzyme activity alongside expression levels

• Temporal considerations:

  • Early vs. late effects may differ substantially

  • Acute vs. chronic models often yield different results

  • Time-course experiments are essential for resolving temporal conflicts

A notable example is seen in cancer research, where Ptges knockout in mouse lung tumor cells results in different outcomes depending on the immune status of the host: tumors still form in immune-deficient nude mice but not in immune-competent mice . This apparently conflicting result actually reveals the immunomodulatory mechanism of Ptges in cancer, highlighting how apparent contradictions can lead to mechanistic insights when properly analyzed.

What are the best approaches for analyzing Ptges expression in heterogeneous tissue samples?

Analyzing Ptges expression in heterogeneous tissue samples presents unique challenges that require specialized approaches:

Single-Cell and Spatial Technologies:

• Single-cell RNA sequencing (scRNA-seq):

  • Resolves cell-type specific expression patterns

  • Identifies rare cell populations with high Ptges expression

  • Reveals cellular heterogeneity masked in bulk analysis

• Spatial transcriptomics:

  • Preserves spatial information about Ptges expression

  • Maps expression to specific tissue microenvironments

  • Correlates with histological features

• Multiplex immunofluorescence:

  • Simultaneously detects Ptges and cell type markers

  • Quantifies protein at the single-cell level

  • Allows correlation with morphological features

Computational Deconvolution Approaches:

For bulk RNA-seq or microarray data from heterogeneous samples, computational deconvolution can estimate cell-type specific contributions:

Statistical Considerations:

• Apply appropriate normalization methods for heterogeneous samples

• Incorporate mixed-effects models to account for within-sample correlation

• Use bootstrapping approaches to estimate confidence intervals

• Consider batch effects and technical variables in study design

When analyzing Ptges expression in tissue samples, it's particularly important to consider immune cell infiltration, as these cells often express high levels of Ptges upon activation . The relative proportion of immune cells in a sample can dramatically affect bulk expression measurements and lead to misinterpretation if not properly accounted for.

How can researchers differentiate between direct Ptges-mediated effects and secondary pathway activation?

Distinguishing direct Ptges-mediated effects from secondary pathway activation requires sophisticated experimental approaches and careful analysis:

Mechanistic Dissection Strategies:

• Genetic rescue experiments:

  • Reintroduce wild-type or catalytically inactive Ptges into knockout backgrounds

  • Compare phenotypic rescue with enzyme activity restoration

  • Use domain-specific mutants to identify structure-function relationships

• Temporal inhibition studies:

  • Apply Ptges inhibitors at different time points during response

  • Use inducible knockout systems for temporal control

  • Correlate immediate versus delayed effects with pathway activation timelines

• Direct target identification:

  • Perform receptor antagonist studies to block PGE2 signaling

  • Use specific EP receptor (EP1-4) antagonists to identify receptor dependencies

  • Measure immediate downstream mediators (cAMP, Ca2+ mobilization) as proximal readouts

Pathway Analysis Framework:

Critical Controls:

• Pharmacological validation:

  • Compare genetic knockout with selective inhibitors

  • Use structurally distinct inhibitors to confirm target specificity

  • Include appropriate vehicle controls

• Dose-response relationships:

  • Establish quantitative relationships between Ptges activity and observed effects

  • Correlate PGE2 levels with biological outcomes

• Cross-species validation:

  • Confirm effects in multiple model systems

  • Leverage evolutionary conservation to identify core pathways

A concrete example comes from research on the immunosuppressive role of Ptges in cancer, where studies demonstrated that Ptges/PGE2 signaling exerts effects through two distinct mechanisms: intrinsically making tumor cells resistant to T-cell cytotoxicity and extrinsically inducing cytokines for MDSC recruitment . This two-pronged mechanism was elucidated through careful experimental design that distinguished between tumor cell-autonomous effects and impacts on the immune microenvironment.

What are the emerging roles of Ptges in metabolic regulation and disease?

Recent research has uncovered several novel roles for Ptges in metabolic regulation, expanding our understanding beyond its classical inflammatory functions:

Adipose Tissue Biology:

• Ptges expression in adipose tissue responds to nutritional status and inflammatory stimuli

• PGE2 production influences adipocyte differentiation and function

• Preliminary evidence suggests Ptges may regulate thermogenic programs in brown and beige adipose tissue

Hepatic Metabolism:

• Liver-specific Ptges activity affects glucose homeostasis through multiple mechanisms

• PGE2 signaling modulates hepatic insulin sensitivity and glycogen metabolism

• Increasing evidence connects Ptges to lipid metabolism and fatty liver disease progression

Pancreatic Function:

• Ptges-derived PGE2 influences insulin secretion from pancreatic β-cells

• Inflammatory activation of Ptges may contribute to β-cell dysfunction in diabetes

• Emerging research suggests roles in α-cell function and glucagon secretion

Energy Expenditure Regulation:

• Central nervous system effects of PGE2 influence feeding behavior and energy expenditure

• Fever generation through hypothalamic PGE2 represents a significant energy-consuming process

• Skeletal muscle energy utilization may be modulated by local Ptges activity

Metabolic Inflammation Interface:
The most compelling emerging role for Ptges lies at the intersection of inflammation and metabolism, where it appears to serve as a key mediator translating inflammatory signals into metabolic adaptations. This is particularly relevant in conditions characterized by meta-inflammation, such as obesity and type 2 diabetes.

These emerging functions suggest that Ptges inhibitors may have therapeutic potential beyond inflammatory conditions, potentially extending to metabolic disorders. Future research directions should include tissue-specific knockout studies focusing on metabolic tissues and detailed characterization of the metabolic phenotypes resulting from Ptges modulation.

How is Ptges involved in regulating cell death pathways and tissue repair?

Ptges plays sophisticated roles in both cell death regulation and subsequent tissue repair processes:

Cell Death Regulation:

Recent research has revealed that Ptges-derived PGE2 functions as a damage-associated molecular pattern (DAMP) released by dying cells . This release occurs during multiple forms of cell death:

• Necrosis

• Pyroptosis (ATP/LPS-induced)

• Apoptosis (cisplatin/etoposide-induced)

The released PGE2 serves as a negative regulator of cell death-induced inflammatory responses , creating a feedback mechanism that prevents excessive inflammation following tissue damage.

Additionally, Ptges expression can be induced by the tumor suppressor protein p53 (TP53) and may be involved in p53-induced apoptosis , suggesting a complex relationship with programmed cell death pathways.

Tissue Repair Mechanisms:

Following tissue damage, Ptges-derived PGE2 influences multiple phases of the repair process:

• Inflammatory phase:

  • Modulates neutrophil and macrophage recruitment and function

  • Helps establish resolution timing through negative feedback

  • Regulates vascular permeability and edema formation

• Proliferative phase:

  • Stimulates fibroblast proliferation and migration

  • Promotes angiogenesis through VEGF induction

  • Influences stem/progenitor cell behavior in multiple tissues

• Remodeling phase:

  • Modulates extracellular matrix production and remodeling

  • Affects myofibroblast differentiation and function

  • Influences scar formation and tissue architecture restoration

Therapeutic Implications:

Understanding the dual roles of Ptges in cell death and repair suggests potential therapeutic strategies:

• Temporal targeting of Ptges may allow modulation of specific repair phases

• Tissue-specific Ptges inhibition could optimize repair while minimizing inflammation

• Combined therapies targeting both Ptges and specific repair pathways may improve outcomes in chronic inflammatory conditions

These findings highlight the complex, context-dependent functions of Ptges across the cell death and tissue repair continuum, emphasizing the need for sophisticated experimental approaches to fully elucidate its roles in different tissues and disease states.

What are the most promising approaches for developing selective mouse Ptges inhibitors for research applications?

The development of selective mouse Ptges inhibitors for research applications has progressed significantly, with several approaches showing promise:

Structure-Based Design Strategies:

With advances in structural biology, rational design approaches have yielded several promising scaffold classes:

• Indole derivatives:

  • Target the enzyme active site with high specificity

  • Show favorable pharmacokinetic properties in mouse models

  • Several compounds demonstrate nanomolar potency

• Phenanthrene imidazoles:

  • Bind allosterically to modify enzyme conformation

  • Demonstrate selectivity over related enzymes

  • Show good brain penetration for CNS studies

• Modified carbazoles:

  • Interact with both the active site and membrane-binding domains

  • Exhibit prolonged tissue retention in mouse models

  • Reduced off-target effects compared to earlier inhibitors

Comparative Inhibitor Profiles:

Validation Approaches:

To ensure research utility, comprehensive validation is essential:

• In vitro validation:

  • Enzymatic assays with recombinant protein

  • Cell-based activity measurements

  • Selectivity profiling against related enzymes

• Ex vivo assessments:

  • Tissue explant studies for efficacy verification

  • Microsomal stability testing

  • Protein binding determinations

• In vivo confirmation:

  • PK/PD relationship establishment

  • Target engagement biomarkers

  • Efficacy in disease models compared to genetic knockout

Current evidence suggests that selective Ptges inhibitors show particular promise in cancer models, where they can suppress MDSC recruitment, restore T cell function, and significantly repress metastasis . This application highlights the potential of these research tools for investigating immunomodulatory mechanisms.

For researchers developing or using these inhibitors, it's critical to remember that compensatory mechanisms may emerge in chronic dosing paradigms, necessitating careful experimental design and interpretation.